Raymond Fink
Endocrinology, Diabetes & Metabolism · la Mesa, CANPI 1164414652
Payments from drug & device makers
Across 1,009 payments — averaging $372.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$274K
- Eli Lilly$69K
- Dexcom, Inc.$22K
- Chiasma, Inc.$8K
- Sanofi-aventis U.S. LLC$357
- Amgen$342
- plus $2K from 18 others
Across 4 payments — averaging $1790.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$7K
What the payments were for
- Food & beverage$2,23398%
- Education$422%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 864 | $274,190 |
| Eli Lilly | 14 | $69,348 |
| Dexcom, Inc. | 10 | $21,861 |
| Chiasma, Inc. | 3 | $8,232 |
| Sanofi-aventis U.S. LLC | 19 | $357 |
| Amgen(2 entities) | 14 | $342 |
| AstraZeneca | 15 | $315 |
| Lilly USA, LLC | 19 | $255 |
| Amryt Pharma Holdings Ltd | 1 | $204 |
| Merck | 8 | $128 |
| Shire North American Group Inc | 7 | $119 |
| Radius Health, Inc. | 5 | $117 |
| AbbVie | 5 | $83 |
| Insulet Corporation | 4 | $76 |
| Novo Nordisk | 4 | $68 |
| Tandem Diabetes Care, Inc. | 3 | $56 |
| Companion Medical, Inc. | 2 | $54 |
| Boehringer Ingelheim | 3 | $50 |
| Valeritas, Inc. | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $31 |
| Mannkind Corporation | 2 | $25 |
| Johnson & Johnson | 1 | $24 |
| BD | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $15 |
How this compares
$376,019 in reported general payments places this provider in the 90th percentile of 952 endocrinology, diabetes & metabolism providers in California.
See all endocrinology, diabetes & metabolism providers in California →
Other endocrinology, diabetes & metabolism in la Mesa
- Jerrold OlefskySan Diego$26.5M
- Mark ChristiansenWalnut Creek$22.9M
- Timothy BaileyEscondido$22.3M
- Stanley HsiaLos Angeles$19.8M
- Juan FriasSan Diego$14.1M
- Paul NorwoodFresno$6.2M
- Athena Philis-Tsimikasla Jolla$6M
- David AhnNewport Beach$5.8M
- Shlomo MelmedLos Angeles$3.3M
- Leila ChaychiSan Carlos$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.